Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Summit Technology

This article was originally published in The Gray Sheet

Executive Summary

Ophthalmic excimer laser maker completes acquisition of Autonomous Technologies for cash and stock valued at $224 mil. The amount is more than double the previously estimated value of $86.6 mil. when the deal was announced in October 1998, due to recent gains in Summit's stock market value ("The Gray Sheet" Nov. 9, 1998, p. 7). Autonomous shareholders will receive .727 shares of Summit common stock and $3.04 in cash for each of their shares. The deal will total about 11.2 mil. Summit shares and $46.8 mil. in cash

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel